Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

The DNA testing company 23andMe is facing serious financial concerns and has announced major restructuring. CBS News ...

No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. 23andMe said Monday it will lay off ...

A company representative shows off what is in a DNA kit at the 23andMe booth at the RootsTech annual genealogical event in ...

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

US-based genetic analysis start-up 23andMe reported a drop in revenue in its latest quarter – on Tuesday, a day after the ...

Anne Wojcicki; Chairman of the Board, President, Chief Executive Officer, Co-Founder; 23andMe Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer; 23andMe Holding ...